Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2021-10-14 2021-09-27
Drug Identification Number 02402475 02402475
Brand name ORENCIA ORENCIA
Common or Proper name Abatacept Abatacept
Company Name BRISTOL-MYERS SQUIBB CANADA BRISTOL-MYERS SQUIBB CANADA
Ingredients ABATACEPT ABATACEPT
Strength(s) 125MG 125MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 4 x 1mL 4 x 1mL
ATC code L04AA L04AA
ATC description IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2021-09-27 2021-09-27
Actual start date 2021-09-27 2021-09-27
Estimated end date 2021-10-31 2021-10-31
Actual end date 2021-10-13
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Allocation will be based on historical demand. Allocation will be based on historical demand.
Health Canada comments